This announcement is a separate document:
麗珠醫藥：內幕消息 建議分拆麗珠試劑及於全國中小企業股份轉讓系統掛牌
LIVZON PHARMA: INSIDE INFORMATION PROPOSED SPIN-OFF AND LISTING OF LIVZON DIAGNOSTICS ON NATIONAL EQUITIES EXCHANGE AND QUOTATIONS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.